A detailed history of Guggenheim Capital LLC transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Guggenheim Capital LLC holds 35,710 shares of JAZZ stock, worth $4.34 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
35,710
Previous 47,210 24.36%
Holding current value
$4.34 Million
Previous $5.04 Million 21.0%
% of portfolio
0.03%
Previous 0.04%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$100.57 - $116.37 $1.16 Million - $1.34 Million
-11,500 Reduced 24.36%
35,710 $3.98 Million
Q2 2024

Aug 14, 2024

BUY
$103.94 - $118.98 $53,840 - $61,631
518 Added 1.11%
47,210 $5.04 Million
Q1 2024

May 14, 2024

BUY
$115.19 - $132.77 $157,925 - $182,027
1,371 Added 3.03%
46,692 $5.62 Million
Q4 2023

Feb 14, 2024

SELL
$114.26 - $136.0 $820,044 - $976,072
-7,177 Reduced 13.67%
45,321 $5.57 Million
Q3 2023

Nov 14, 2023

SELL
$122.0 - $145.31 $526,308 - $626,867
-4,314 Reduced 7.59%
52,498 $6.8 Million
Q2 2023

Aug 11, 2023

BUY
$122.5 - $147.16 $427,157 - $513,146
3,487 Added 6.54%
56,812 $7.04 Million
Q1 2023

May 10, 2023

SELL
$133.98 - $160.47 $166,001 - $198,822
-1,239 Reduced 2.27%
53,325 $7.8 Million
Q4 2022

Feb 14, 2023

BUY
$129.72 - $159.85 $1.18 Million - $1.45 Million
9,075 Added 19.95%
54,564 $8.69 Million
Q3 2022

Nov 14, 2022

SELL
$126.59 - $161.18 $466,737 - $594,270
-3,687 Reduced 7.5%
45,489 $6.06 Million
Q2 2022

Aug 15, 2022

BUY
$141.59 - $168.66 $2.19 Million - $2.61 Million
15,486 Added 45.97%
49,176 $7.67 Million
Q1 2022

May 16, 2022

SELL
$129.64 - $160.7 $6.06 Million - $7.52 Million
-46,777 Reduced 58.13%
33,690 $5.25 Million
Q4 2021

Feb 14, 2022

BUY
$119.87 - $145.67 $3.21 Million - $3.9 Million
26,778 Added 49.88%
80,467 $10.3 Million
Q3 2021

Nov 15, 2021

SELL
$128.64 - $184.79 $532,183 - $764,476
-4,137 Reduced 7.15%
53,689 $6.99 Million
Q2 2021

Aug 13, 2021

SELL
$160.2 - $186.42 $1.79 Million - $2.08 Million
-11,152 Reduced 16.17%
57,826 $10.3 Million
Q1 2021

May 13, 2021

SELL
$150.19 - $173.5 $2.02 Million - $2.33 Million
-13,446 Reduced 16.31%
68,978 $11.3 Million
Q4 2020

Feb 16, 2021

BUY
$140.71 - $165.05 $1.95 Million - $2.28 Million
13,835 Added 20.17%
82,424 $13.6 Million
Q3 2020

Nov 13, 2020

SELL
$105.46 - $144.13 $1.36 Million - $1.86 Million
-12,884 Reduced 15.81%
68,589 $9.78 Million
Q2 2020

Aug 14, 2020

BUY
$95.68 - $121.88 $1.47 Million - $1.87 Million
15,362 Added 23.24%
81,473 $8.99 Million
Q1 2020

Jun 02, 2020

SELL
$87.74 - $152.74 $1.29 Million - $2.25 Million
-14,716 Reduced 18.21%
66,111 $6.59 Million
Q4 2019

Feb 14, 2020

BUY
$117.65 - $153.73 $2.93 Million - $3.83 Million
24,941 Added 44.63%
80,827 $12.1 Million
Q3 2019

Nov 14, 2019

SELL
$125.18 - $143.24 $281,905 - $322,576
-2,252 Reduced 3.87%
55,886 $7.16 Million
Q2 2019

Aug 14, 2019

SELL
$125.55 - $144.48 $763,846 - $879,016
-6,084 Reduced 9.47%
58,138 $8.29 Million
Q1 2019

May 15, 2019

SELL
$121.81 - $142.95 $2.02 Million - $2.37 Million
-16,601 Reduced 20.54%
64,222 $9.18 Million
Q4 2018

Feb 14, 2019

SELL
$115.94 - $166.74 $1.1 Million - $1.58 Million
-9,492 Reduced 10.51%
80,823 $10 Million
Q3 2018

Nov 14, 2018

BUY
$161.01 - $180.57 $9.43 Million - $10.6 Million
58,563 Added 184.44%
90,315 $15.2 Million
Q2 2018

Aug 14, 2018

SELL
$146.33 - $183.18 $127,453 - $159,549
-871 Reduced 2.67%
31,752 $5.47 Million
Q1 2018

May 15, 2018

SELL
$135.59 - $157.16 $244,062 - $282,888
-1,800 Reduced 5.23%
32,623 $4.93 Million
Q4 2017

Feb 14, 2018

SELL
$131.06 - $150.39 $1.31 Million - $1.51 Million
-10,009 Reduced 22.53%
34,423 $4.64 Million
Q3 2017

Nov 14, 2017

BUY
$142.62 - $155.6 $6.34 Million - $6.91 Million
44,432
44,432 $6.5 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.63B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Guggenheim Capital LLC Portfolio

Follow Guggenheim Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.